Home > Boards > US OTC > Biotechs >

Tasco Holdings (THII)

Add THII Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 9/7/2006 3:38:08 PM - Followers: 0 - Board type: Free - Posts Today: 0

BIO-MATRIX SCIENTIFIC GROUP, INC. - A Stem Cell Company (A Subsidiary of Tasco Holdings International, Inc. - OTCBB: THII) Princeton Research July 14, 2006 Volume I, Issue 2 Current Price: $2.80 Target Price: $7.70 • As of June 14, 2006, all members of the Tasco Holdings International board resigned and elected Dr. David R. Koos and Mr. Brian Pockett as incoming Directors of Tasco Holdings International. • Shareholders of BMXP to receive a THII dividend. • Company Name change of the Tasco Holdings International, Inc. and THII symbol to agreement with Bio-Matrix Scientific Group is pending. SPECIALIZING In STEM CELL BANKING And DISPOSABLE INSTRUMENTATION SOLUTIONS For STEM CELL THERAPIES Bio-Matrix Scientific Group Inc. (OTC BB: THII) is aligning itself with partners that offer support of key technologies in medical applications. This new placement after reversemerging into Tasco Holdings International, Inc. will help them achieve the financing for those projects which they have focused on the best: invention and securing intellectual property rights to the medical processes and devices that are critical to the biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Originally they were dedicated to the research and development of disposable devices and instruments critical to the stem cell research and tissue transfer medical applications. During that time they have developed 192 different instruments for service in the plastic surgery, stem cell and tissue management fields. The Bio-Matrix link to plastic surgery has helped launch their next step. They have constructed new labs and a cryogenic storage facility for patients wishing to preserve their own stem cells, taken from adipose (fat tissue) extracted from a patient during the liposuction process. In the event the patient requires stem cell therapy for treatment of a future health problem, these stem cells may then be taken from the adipose tissue that has been cryo-preserved. This process of using adipose tissue derived stem cell previously cryo-preserved provides several benefits for the patient, above all reducing the risk of cell tissue rejection by eliminating donor issues. Likewise, the facility may be used to store a newborn “cord blood” stem cells for possible therapies that might be required later in life. Stem cell therapies are now being seen to assist in the treatment of several diseases associated with aging, such as Parkinson’s and Alzheimer’s Disease. With the emphasis on continuing research and development, Bio- Matrix Scientific Group may well be a mainstay contributor to the future’s innovative therapies. They continue to seek improvement and ways to develop more instruments and products to suit the demands of plastic surgery, stem cell and tissue research. The goal of their organization mission is to ultimately enhance the quality of life. Lab technician preparing cell culture “ This is a $7 to $8 stock. With less than 13 million shares outstanding, THII deserves capitalization of 75-85 million dollars. Bio- Matrix has made incredible strides some of the most exciting and innovative concepts in biotechnology. The process of removing unwanted tissue (fat) and saving it for its stem cell use in the possibility of future need is a breakthrough step. This will continue to prove itself to be an incredible investment opportunity. ” Mike King, Director of Princeton Research, Inc. www.BMXGonline.com Cryogenic Tank Liquid Nitrogen Storage Clean Room Piping THII Shares Outstanding: 12,700,000 Float: 2,700,000 Page 2 Bio-Matrix Scientific Group July 14, 2006 Bio-Matrix Scientific Group’s Plastic Surgery Connection The American Society of Plastic Surgeons records on the most popular Cosmetic Surgery Procedures shows that in the last 5 years, Liposuction has risen to become the most common. The number of surgeries comprising the top 5 has diminished by 10% in five years, but in part due to new processes that are substituting as intermediary treatments. For example, facelifts are now off of the top 5 because of the advent of collagen and botox injections as a less invasive means of achieving a similar appearance result. For all of the top procedures, Bio-Matrix Scientific Group’s surgical instrument kits have been developed for providing direct assistance to the surgeon. They additionally have six provisional patent applications, a utility patent application, and an international patent application for proprietary devices developed exclusively for cell harvesting and tissue transfer procedures. Statistics from 2000 The term "forward-looking statements" is defined in Section 27A of the Securities Act of 1933 as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934 as amended the “Exchange Act.” This article’s statements, with the exception of historical fact statements, are reasonable; the company, however, can give no assurance that such expectations will prove different. This article’s forward-looking statements are within the meaning of the Private Securities Litigation Reform Act of 1995. While Bio-Matrix Scientific Group, Inc. believes its research, performance, forecasting and assumptions are reasonable, there are some external factors that are hard to predict and influenced by economic and other conditions that can influence the outcome of performance. Princeton Research, Inc. has accepted compensation from Bio-Matrix Scientific Group, Inc. in the form of 25,000 shares of restricted shares for investor relations. Marketing Strategy • Educate the medical professionals of selected specialties in the technology services of Bio-Matrix. • Build and maintain these professional relationships as a resource. • Acquire service customers through medical professionals. • Utilize a sophisticated team of scientists and medical professionals to keep communications and relations open with specialists for needs analysis and further development. • Visibility through participation in professional association meetings and conferences, business media releases, and community participation.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#19   What happens now with Frezer Inc shares - phoenixdove 09/07/06 03:36:31 PM
#18   Lebed pumping...er profiling, THII: BULListic 08/30/06 11:53:16 AM
#17   Tasco Holdings Files to Change Name to Bio-Matrix lady*b 08/29/06 08:34:09 AM
#16   COMPANY SPOTLIGHT - THII JJdivini 08/28/06 09:32:45 AM
#15   www.lifesavingstemcells.com JJdivini 08/28/06 09:03:00 AM
#14   Tasco Holdings Chairman & CEO David Koos Featured JJdivini 08/28/06 08:55:23 AM
#13   Showing signs of life ! JJdivini 08/25/06 11:58:04 AM
#12   on the MOVE ! JJdivini 08/10/06 12:57:47 PM
#11   LOOK AT THIS !!! JJdivini 08/03/06 02:46:51 PM
#10   Tasco's Bio-Matrix Scientific Unit Installs New, Cutting-Edge Stem JJdivini 08/02/06 10:13:22 AM
#9   SAFE, go to www.bigcharts.com JJdivini 07/31/06 12:08:53 PM
#8   StockGuru.com Announces Profile Coverage of Tasco Holdings International JJdivini 07/31/06 12:02:21 PM
#7   StockCharts don't have a chart on it yet. Safemaster 07/29/06 03:36:46 PM
#6   Looking good today ! JJdivini 07/26/06 12:12:14 PM
#5   Tasco Holdings International Rated 'Outperform,' Target $6.00 by JJdivini 07/26/06 09:31:09 AM
#4   Tasco Holdings International Favorably Profiled in OTC Financial JJdivini 07/25/06 10:14:10 AM
#3   http://www.otcfn.com/thii/index.html JJdivini 07/24/06 03:56:57 PM
#2   Tasco Holdings International Retains OTC Financial Network for JJdivini 07/21/06 12:32:40 PM
#1   LOS ANGELES, CA -- (MARKET WIRE) -- 07/21/06 JJdivini 07/21/06 12:29:04 PM
Consent Preferences